Peter Lawson
Stock Analyst at Barclays
Total Price Targets
18
Stocks Covered
11
Sectors
Healthcare
Most Recent
Nov 4, 2025
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Peter Lawson
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals, Inc. | $22.00 | $19.18 | +14.7% | 2 | Nov 4, 2025 |
| INCY | Incyte Corporation | $101.00 | $96.41 | +4.8% | 1 | Oct 29, 2025 |
| MGNX | MacroGenics, Inc. | $3.00 | $3.16 | -5.1% | 3 | May 14, 2025 |
| GERN | Geron Corporation | $4.00 | $1.58 | +152.4% | 1 | Feb 27, 2025 |
| BMEA | Biomea Fusion, Inc. | $11.00 | $1.36 | +705.9% | 2 | Oct 30, 2024 |
| RLAY | Relay Therapeutics, Inc. | $17.00 | $12.90 | +31.7% | 3 | Sep 9, 2024 |
| RCUS | Arcus Biosciences, Inc. | $25.00 | $25.66 | -2.6% | 2 | Jul 8, 2024 |
| REPL | Replimune Group, Inc. | $13.00 | $2.46 | +429.5% | 1 | Jun 4, 2024 |
| EXEL | Exelixis, Inc. | $25.00 | $43.81 | -42.9% | 1 | Apr 11, 2024 |
| IOVA | Iovance Biotherapeutics, Inc. | $40.00 | $3.40 | +1074.7% | 1 | May 19, 2021 |
| AGIO | Agios Pharmaceuticals, Inc. | $70.00 | $28.15 | +148.7% | 1 | Apr 30, 2021 |
Recent Activity
- Nov 4, 2025— Set$22.00price target onSNDX(Syndax Pharmaceuticals, Inc.)
- Oct 29, 2025— Set$101.00price target onINCY(Incyte Corporation)
- May 14, 2025— Set$3.00price target onMGNX(MacroGenics, Inc.)
- Feb 27, 2025— Set$4.00price target onGERN(Geron Corporation)
- Oct 30, 2024— Set$11.00price target onBMEA(Biomea Fusion, Inc.)
- Sep 9, 2024— Set$17.00price target onRLAY(Relay Therapeutics, Inc.)
- Aug 15, 2024— Set$33.00price target onSNDX(Syndax Pharmaceuticals, Inc.)
- Jul 29, 2024— Set$9.00price target onMGNX(MacroGenics, Inc.)
- Jul 8, 2024— Set$25.00price target onRCUS(Arcus Biosciences, Inc.)
- Jun 7, 2024— Set$5.00price target onBMEA(Biomea Fusion, Inc.)
- Jun 4, 2024— Set$35.00price target onRCUS(Arcus Biosciences, Inc.)
- Jun 4, 2024— Set$13.00price target onREPL(Replimune Group, Inc.)
- May 10, 2024— Set$15.00price target onRLAY(Relay Therapeutics, Inc.)
- May 10, 2024— Set$14.00price target onMGNX(MacroGenics, Inc.)
- Apr 11, 2024— Set$25.00price target onEXEL(Exelixis, Inc.)
- Sep 30, 2022— Set$23.00price target onRLAY(Relay Therapeutics, Inc.)
- May 19, 2021— Set$40.00price target onIOVA(Iovance Biotherapeutics, Inc.)
- Apr 30, 2021— Set$70.00price target onAGIO(Agios Pharmaceuticals, Inc.)
Frequently Asked Questions
Who is Peter Lawson?
Peter Lawson is a stock analyst at Barclays covering 11 stocks primarily in Healthcare. They have issued 18 price targets since Apr 30, 2021.
What stocks does Peter Lawson cover?
Peter Lawson currently covers 11 stocks, including MGNX, RLAY, SNDX, BMEA, RCUS.
What is Peter Lawson's latest price target?
Peter Lawson's most recent price target was $22.00 on SNDX (Syndax Pharmaceuticals, Inc.), set on Nov 4, 2025.
What is Peter Lawson's highest price target?
Peter Lawson's highest issued price target is $101.00 on INCY, set on Oct 29, 2025.
More Analysts at Barclays
Coverage based on publicly published price targets. Not investment advice.